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Abstract 
Oeppen and Vaupel (2002) revolutionized the field of human mortality forecasting by 
showing that best-practice life expectancy has risen almost linearly from the mid-
nineteenth century to the present. In this paper, we present a methodology that makes 
use of that finding. We show that among a set of 14 low mortality countries, the 
distribution of life expectancies in the last 40 years has had almost perfectly linear mean 
and median values. We use this observation to estimate the parameters of models that 
include both trend error and idiosyncratic error. We compare the outcomes of the new 
procedure with the United Nations (2003) forecasts for Germany, Japan, and the U.S., 
where only mortality rates differ. The projections are most similar for Japan and most 
different for the U.S. 
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Putting Oeppen and Vaupel to Work:  On the 
Road to New Stochastic Mortality Forecasts 
Warren Sanderson and Sergei Scherbov 
1. Introduction 
Oeppen and Vaupel (2002) revolutionized the field of human mortality forecasting. 
They demonstrated that best-practice life expectancy has risen almost linearly from the 
1850s to 2000. To this they added a long list of forecasts of limits to human life 
expectancy that have consistently been proven wrong. While there is certainly no 
guarantee that the linear rise in best-practice life expectancy will continue into the 21st 
century, neither is there a compelling argument that it will not. In particular, there is 
certainly no reason to believe that the year 2000 marked a watershed between a 150-
year period of rapid increases in best-practice life expectancy and a subsequent period 
of much slower gains. The most plausible belief, based on Oeppen and Vaupel (2002), 
is that, at least in the short run, the remarkable linearity in best-practice life expectancy 
will remain with us. This paper demonstrates one way to apply the Oeppen and Vaupel 
(2002) finding in mortality forecasting. 
Oeppen and Vaupel (2002) concentrated on best-practice life expectancy 
because their point was that there is no indication that human life expectancy is nearing 
a limit. Read narrowly, their work pertains only to a particular order statistic of 
historical life expectancy distributions. Read more broadly, Oeppen and Vaupel (2002) 
show that interesting properties emerge when we consider the distribution of life 
expectancy histories across countries – properties that we would not see if we are 
considering each country separately. We began looking for other potentially interesting 
and useful properties by asking the question: Is the linearity that Oeppen and Vaupel 
observed a characteristic only of best-practice life expectancy, or is it a more general 
characteristic of the whole group of countries that are experiencing low mortality? To 
answer this question and to put the Oeppen and Vaupel (2002) finding into perspective, 
we took the most recent 40 years of data from 14 countries with high life expectancies 
in the Human Mortality Database (2004). We excluded countries of the former Warsaw 
Pact because their recent mortality histories could have been affected by the significant 
political and economic changes they experienced.  The countries are: Austria, Canada, 
Denmark, England and Wales, Finland, France, (Western) Germany, Italy, Japan, the 
Netherlands, Norway, Sweden, Switzerland, and the United States. Their recent life 
expectancy histories (for females) can be seen in Figure 1. 
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Figure 1. Life expectancy of females in 14 countries with high life expectancies in the 
Human Mortality Database (2004). 
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Figure 2. Best-practice and the mean life expectancy of females in 14 countries with 
high life expectancies in the Human Mortality Database (2004). 
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Figure 2 clearly answers the question. The graph showing best-practice life 
expectancy is nearly linear, of course, but so is the graph of the mean of the life 
expectancy distributions. Indeed, the rate of increase of mean life expectancy and best-
practice life expectancy are practically identical, around 2.1 years per decade for the 
mean and 2.2 years for best practice, and these are statistically indistinguishable from 
one another. In other words, the linearity that Oeppen and Vaupel observed is not only a 
characteristic of best-practice life expectancy, but, at least recently, it has also been a 
general feature of the means of the distributions of life expectancies in low mortality 
countries. 
Fortunately, we do not lack methods for making stochastic mortality forecasts. 
But do they put Oeppen and Vaupel (2002) to work? The most famous and most widely 
used method of making stochastic mortality forecasts is the Lee-Carter method (Lee and 
Carter 1992). Table 1 shows the predicted life expectancies (both sexes combined) for 
seven low mortality countries using the Lee-Carter method (Tuljapurkar et al. 2000) and 
the corresponding observed increases in life expectancies over the last two decades. 
 
Table 1. Observed and predicted increases in life expectancies for both sexes combined. 
Sources: Forecasts for the Lee-Carter model are from Tuljapurkar et al. (2000); 
observed life expectancies from the Human Mortality Database (2004). 
Country Observed increase of 
life expectancy per 
decade (time period) 
Lee-Carter predicted 
increase in median life 
expectancy per decade: 
2000-2020 
Lee-Carter predicted 
increase in median life 
expectancy per decade: 
2020-2050 
Canada 1.78 
(1976-1996) 
1.41 1.20 
France 2.21 
(1981-2001) 
1.74 1.5 
Germany 2.29a 
(1979-1999) 
1.28 1.14 
Italy 2.60 
(1980-2000) 
1.63 1.35 
Japan 2.62 
(1979-1999) 
2.27 1.63 
UK 1.85b 
(1978-1988) 
1.32 1.22 
US 0.87 
(1979-1999) 
1.35 1.22 
Median 2.21 1.41 1.22 
Average 2.03 1.57 1.32 
 
a
 Former Federal Republic of Germany (West Germany) 
b
 England and Wales 
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Clearly, the answer is that the Lee-Carter method does not put Oeppen and 
Vaupel (2002) to work. First, note that the mean observed increase in life expectancy 
over the last 20 years of available data was 2.0 years per decade. That is consistent with 
the 2.1 years per decade increase that we observe over a nearly 40-year period in our 
14-country sample shown in Figure 2. The predictions for the first two decades of the 
21st century using the Lee-Carter model clearly are very different from the change in life 
expectancies observed in the last two decades. The mean increase falls from 2.0 to 1.6 
years. If we were to believe the Lee-Carter results, we would have to believe that the 
year 2000 saw a downward shift in the trend of life expectancy increases. There is no 
evidence so far that this has been the case. 
Second, note that the Lee-Carter forecasts show the continuing decreases in 
additional years of life expectancy per decade. In contrast, Oeppen and Vaupel (2002) 
show a remarkable consistency in the increase in life expectancy for the best-practice 
case, and Figure 2 shows that, at least in the last four decades of the 20th century, the 
same was true for the mean of 14 low mortality countries. One can, of course, argue that 
around the beginning of the 21st century the pattern of life expectancy increase changed 
– that the future of life expectancy increases will no longer be like the past. But again to 
make this argument convincing, its proponents would need some evidence. As Oeppen 
and Vaupel (2002) show, the past is littered with incorrect forecasts based on the 
presumption that we were nearing the limit to human life expectancy. The Lee-Carter 
forecasts do not assume such a limit, but they do show a remarkable and continuing 
slowing in life expectancy gains. Third, the Lee-Carter approach forecasts continuing 
and increasing gaps in life expectancy between the countries, although history shows 
that countries may lag behind and after a while become leaders. Clearly, the Lee-Carter 
method does not put Oeppen and Vaupel (2002) to work and therefore, we must 
continue looking for an approach that does. 
Keilman et al. (2002) use a different methodology for making probabilistic 
mortality forecasts for Norway. They use annual life expectancies at birth in Norway 
from 1945 to 1995 separately for men and women, and estimate a multivariate ARIMA 
(2,0,0) model. However, they modify their estimated coefficients so that median 
forecasted life expectancies for men and women in 2050 match those assumed in the 
1999 forecast made by Statistics Norway. That agency assumed that male life 
expectancy would rise to 80.0 years and female life expectancy to 84.5 years in 2050. 
Since in 2000, life expectancy for males was 75.95 years and for females was 81.37 
years, the implied increase is a paltry 0.81 years per decade for men and 0.63 years per 
decade for women. For comparison, between 1950 and 2000, the life expectancy of 
males and females increased by 1.21 and 1.62 years per decade, respectively. Clearly, 
the small increases in life expectancy forecasted by Statistics Norway do not put 
Oeppen and Vaupel (2002) to work. Perhaps the ARIMA (2,0,0) model unconstrained 
to match the forecast of Statistics Norway would have. 
In general, adding uncertainty to the medium variant forecasts of official 
organizations does not put Oeppen and Vaupel (2002) to work because those forecasts 
typically show much less life expectancy gain. This can be seen from Table 2, where we 
reproduce forecasts gathered in Lundström (2003). Indeed, most of the official mortality 
forecasts shown there assume increases in life expectancy of less than one year per 
decade over the period 2000 to 2050, less than half the rate of the most recently 
observed changes. 
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Table 2. Average life expectancy for women, 2000-2050. Forecasts in different 
countries. Source: Lundström (2003). 
Country 2000 2010 2020 2030 2040 2050 
France 83 84.8 86.5 87.9 89.2 90.4 
Belgium 81.1 82.3 83.6 85 86.5 88.1 
Austria 81.3 82.8 84.2 85.5 86.2 87 
Switzerland 83 84.4 85.6 86 86.4 86.9 
USA 79.9 81.4 82.9 84.2 85.4 86.6 
Sweden 82.1 83.4 84.4 85.3 86 86.5 
Japan 84.1 85.1 85.6 86 86.3 86.5 
Finland 80.9 82 83.1 84 84.8 85.5 
Italy 82.3 83.5 84.7 84.7 84.7 84.7 
Norway 81.5 82.7 83.5 84.1 84.4 84.5 
UK 80.1 81.5 82.6 83.2 83.6 83.8 
Netherlands 80.6 81.1 81.6 82.2 82.7 83 
Denmark 78.5 78.6 78.6 78.6 78.6 78.6 
 
 
Lutz, Sanderson, and Scherbov (2004, 2001, 1996) have devised two methods 
for stochastic mortality forecasting that, in different ways, are closer to Oeppen and 
Vaupel (2002). We call our two approaches LSS1 and LSS2. They were devised to be 
applied to large regions of the world, not individual countries. Nevertheless, they are 
relevant to our discussion here. In both, the mean value of life expectancy increases 
linearly by two years per decade, and so both are broadly consistent with recent 
observations. In LSS1 (see Lutz et al. 1996) stochastic realizations of life expectancy 
paths are straight lines originating from observed life expectancies in 1995. The trends 
are drawn from a normal distribution with a mean increase of two years of life 
expectancy per decade and with the standard deviation determined so that there would 
always be a five percent chance that life expectancy would be less than it was in 1995. 
LSS1, in other words, had only trend uncertainty; all that uncertainty was immediately 
realized in 1995. Although on average LSS1 captures the observed trends, the individual 
paths do not seem fully consistent with the expectation that the observed trend in life 
expectancy increase would persist, at least in the short run. 
LSS2 (see Lutz et al. 2001, 2004), in contrast, has no trend uncertainty at all and 
has only idiosyncratic uncertainty around a life expectancy trend that increases by two 
years per decade. LSS2, then, is potentially a candidate for putting Oeppen and Vaupel 
(2002) to work. But when we estimated the parameters of the LSS2 model for the 14 
countries in our low mortality sample, we found that the standard deviation of life 
expectancies at the end of the century was much lower than we expected. 
Thus, we had to set off to find a new model that was both consistent with 
Oeppen and Vaupel (2002) and consistent with the empirical data on life expectancy 
changes in our 14 sample countries. It is probably not surprising that we found the most 
consistent model to be one that combined the features of both LSS1 and LSS2. The 
model contains both trend uncertainty and idiosyncratic variation around the uncertain 
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trends. LSS1 and LSS2 are both special cases of model presented here. The combination 
of the features of both is required to fit the data and to make Oeppen and Vaupel work. 
We proceed as follows. In Section 2, we present the new framework and talk 
about how we estimated its parameters for three countries, Germany, Japan, and the 
U.S. The third section contains a comparison of our forecasts for those three countries 
and those of the United Nations (2003). The comparison is constructed so that the 
forecasts differ only in mortality assumptions. We present some concluding thoughts 
about putting Oeppen and Vaupel (2002) to work in Section 4. 
2. The Model and Its Estimation 
We chose the 14 countries from which we took the data based on three criteria: (1) Data 
had to be available for at least 40 years after 1955 in the Human Mortality Database 
(2004), (2) there could be no significant economic or social changes that could have 
caused a break in the long-run trend of life expectancy changes, and (3) all the countries 
had to have high life expectancies. The linearity of the mean life expectancy that we 
saw in Figure 1 and the idea, based on Oeppen and Vaupel (2002), that we can learn 
about mortality change by studying distributions of outcomes, suggested to us that we 
could treat the latest four decades of life expectancy observations for the 14 countries as 
being generated from a common statistical model. That model is: 
( ) ( ) ( )cttcte0 ,, µτ += ,         (1) 
where e0(t,c) is female life expectancy at time t in country c, τ(t) is the mean value of 
the set of 14 female life expectancies at time t, as shown in Figure 1, and µ(t,c) is the 
deviation from the mean at time t in country c. 
As in LSS2, we specify that µ(t) has a moving average representation 
( )
n
x
ct
t
1nti
ci 
+−=
=
,
,
α
µ ,         (2) 
where n is the order of the moving average, the xi,c are independently distributed 
realizations from a standard normal distribution, and the standard deviation of µ(t,c) 
depends on α according to the formula: 
( )( )
n
ctsd αµ =, .         (3) 
The moving average specification in Eq. (2) is unusual because the coefficient 
on each of the moving average terms is constant (= α). We also estimated a model 
where the coefficients varied, but the results were so similar to the constant coefficient 
version in Eq. (2) that we chose the simpler approach. First, we discuss how we estimate 
the two parameters, α and n and then move on to how we use those estimates in our 
forecasts. 
Since both the life expectancies and τ(t), the trend, are observed, we can 
calculate the µ(t,c) from Eq. (1). The µ(t,c) are a function of the two parameters, α and 
n. We estimate these two parameters using the 560 (14 countries times 40 years) 
observations on the µ’s. The autocorrelation function depends only on n and we used 
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this fact to find the value of n that best fit it. We computed the autocorrelation function 
for correlations between the µ(t,c) from one year apart to 30 years apart. For 
autocorrelations i years apart we had ( ) 14i40 ⋅−  pairs of observations. 
To find the value of n that best fit the data, we defined the statistic S as: 
( ) ( ) ( )[ ]( )[ ]
230
1i nigsd
nigi
nS
 
=
 
 
 
 
 
 −
=
,
,γ
,        (4) 
where γ(i) is the observed autocorrelation between the µ(t,c) that are i  years apart (using 
the ( ) 14i40 ⋅−  relevant pairs of observations), g(i,n) is a single simulated measurement 
of the autocorrelation of terms that are i years apart (based on ( ) 14i40 ⋅− pairs of 
simulated values), conditional on there being n terms in the moving average; ( )nig ,  is 
the expected value of the g(i,n) and sd[g(i,n)] is the standard deviation of the 
autocorrelation, computed again assuming the same number of observations used in 
calculating the γ(i). 
The ( )nig ,  and the sd[g(i,n)] were computed using a bootstrap procedure. We 
did 1,000 iterations. In each iteration we took 14 time series from our 14 countries with 
replacement. In other words, in a single iteration, we could include France twice, 
Norway twice, and have no observations for the U.S. or Japan. The probability that a 
single country would be appear only once among the 14 time series in a given iteration 
is 2.7 percent (100*(1/14)*(13/14)^13). We found that the minimum value of S(n) 
occurred at n equals 44. We also computed the ( )nig ,  and the sd[g(i,n)] on the 
assumption that the moving average specification was exactly correct. When we 
minimized S(n), in this case, we obtained an n of 34. The difference between a value of 
n of 44 and 34 makes only a trivial difference in the mortality forecasts. We decided to 
use an n of 44 because it kept us closer to the observed data. 
Using n = 44, we performed the analogous calculation, on the standard 
deviations of life expectancy differences over various spans from one year to 30 years in 
order to compute α. We defined the test statistic D(n) as: 
( ) ( ) ( )[ ]( )[ ]
230
1i idsd
idiD
 
=
 
 
 
 
 
 −
=
α
αδ
α
,
,
,        (5) 
where δ(i) is the observed standard deviation of differences in µ(t,c) values i years apart; 
( )α,id  is the mean value of those standard deviations when we are considering 
differences in µ(t,c) values i years apart, for a specific value of α; and ( )[ ]α,idsd  is the 
standard deviation of ( )α,id . We followed an analogous bootstrap procedure to the one 
described above. We found that D(α) was minimized at α = 7.3, implying a standard 
deviation of the µ(t,c) of 1.1 years of life expectancy. 
The model above is almost identical to the one in Lutz et al. (2001). The main 
difference is that here we estimated a value of α that fit the data for high life expectancy 
countries that did not have a trend shift within the last 40 years of observations. In Lutz 
et al. (2001) we let α increase gradually to reflect the increasing uncertainty of life 
expectancies with the passage of time that we derived from expert opinion. 
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The difference between these two views provides us with both a challenge and 
an opportunity. The annual variability of observed life expectancy paths does not 
increase over time. Nevertheless, our uncertainty about the future certainly increases 
over time. We bridge the gap by adding an element that was crucial in Lutz et al. 
(1996), trend uncertainty. 
Oeppen and Vaupel (2002) make a convincing case that best-practice life 
expectancy is not slowing down. We show that the same has been true of the mean life 
expectancy in our 14 country sample. There is certainly no plausible forecasting 
methodology, which we know of, that suggests that life expectancy trends should 
change at the instant that a forecast begins. Instead, it is more likely that current life 
expectancy trends will continue for a while. But for how long? 
Here we assume that there will be a trend change sometime during the 21st 
century. We assume that the size of the trend shift is more likely to be small than large, 
and that it will occur in a random year between 2002 and the end of the century. The 
probability of a trend shift happening in any given year is 1/97. The first trend shift can 
happen in 2002 and the last in 2099, so each of the 97 years has an equal probability of 
being the one in which the trend shift occurs. We assume that the change in the trend, 
when it happens, has a normal distribution with mean zero. 
Our full model, then, is: 
( ) ( ) ( ) ( ) ( ) ( )ctttccttcte0 ,,, * µηθτ +−⋅⋅+= , 
where ș(t,c) is zero for all the years prior to the trend shift and is unity thereafter, n(c)is 
the value of the trend shift, and t* is the year in which the trend shift occurs. Ș(c) is 
normally distributed with mean zero and standard deviation ν. This leaves us with the 
problem of estimating the standard deviation of the trend change distribution, ν. 
In keeping with the spirit of Oeppen and Vaupel (2002), we decided to estimate 
ν on the basis of observed life expectancies. We used a bootstrap procedure, similar to 
the one we used in the estimation of α, with the life expectancy data for six countries 
that had long time series, England and Wales, Norway, and Sweden (dating back to 
1847), Switzerland (beginning 1876), Italy (beginning 1872), and France (beginning 
1899). The resulting bootstrap measure of the standard deviation of life expectancy 
differences using observations between 80 and 100 years apart was 5.3 years of life 
expectancy. In this paper, we rounded the standard deviation up to 6.0 years of life 
expectancy for predictions 100 years in the future. Our estimate of ν was set so that the 
standard deviation of life expectancy differences 100 years apart is 6.0 years. 
Our incorporation of trend change is consistent with the available time series 
data on life expectancy. Figure 3 shows the long-term evolution of female life 
expectancy in five of the countries that we used in our analysis. Italy was omitted 
because its life expectancy in the late 19th century was considerably lower than the 
other five. Three periods of stable but distinct trends are clearly evident: Prior to 1900, 
1900-1960, and 1960 onwards. We constructed our 14 country sample on the condition 
that their most recent 40-year histories did not include a trend change. This allowed us 
to estimate n and α first and then use those estimates in computing ν from the longer 
time series data. 
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Figure 3.  Long-term evolution of female life expectancy in five countries used in the 
analysis. 
3. The Results 
What difference does it make if we put Oeppen and Vaupel (2002) to work? In order to 
answer this question, we need suitable standards of comparison. The obvious candidates 
here are the UN forecasts. Since our interest is in assessing the effects of putting 
Oeppen and Vaupel (2002) to work, we have produced probabilistic forecasts using 
fertility and migration assumptions that are as close as possible to the United Nations 
(2003) long-run projections. To keep our presentation manageable, we show the results 
only for Germany, Japan, and the United States. 
Figure 4 shows our life expectancy forecasts for Japanese women and the UN 
forecast. The two agree well up to 2050. The UN forecasts a nine year increase in life 
expectancy from 2000 to 2050, a 1.8 year increase per decade. We predict about the 
same, because since Japan has a well above average life expectancy in 2000, our 
methodology requires that its median value will be closer to the trend line in 2050. After 
2050, the UN forecasts a significant slowing in Japan’s life expectancy growth. Female 
life expectancy is projected to grow by three years in the second half of the century, 
from 93 years to 96 years, at a rate of 0.6 years increase per decade. We do not assume 
such a slow down, on average (although half of our life expectancy paths do exhibit a 
slowdown), and show a median life expectancy for Japanese women in 2100 of around 
105 years. 
 10
Figure 4.  Probabilistic forecast of life expectancy and the UN medium variant, Japan, 
females. 
Figure 5. Probabilistic forecast of life expectancy and the UN medium variant, 
Germany, females. 
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Figure 5 shows a similar graph for female life expectancy in Germany. The UN 
forecasts a slower increase in life expectancy there than in Japan in the first half of the 
century, an increase of 1.2 years per decade, and a faster increase in the second half of 
the century, again 1.2 years per decade. After 2020, the forecasted life expectancy for 
German women remains around the 0.025 fractile of our distribution of life 
expectancies. In this case, putting Oeppen and Vaupel (2002) to work implies that the 
UN life expectancy path for German women is rather unlikely. 
Figure 6 shows the corresponding graph for women in the United States. The 
UN life expectancy forecast increases by one year per decade in the 2050 period, and 
only by 1.2 years per decade in the second half of the century. The U.S. is rather far 
below the median of the 14 country sample in 2000, and in this sense is the mirror 
image of the Japanese case. Our methodology assumes that, on average, the U.S. female 
life expectancy will eventually approach the forecasted median line more closely and 
therefore, will on average (in the long run) have faster life expectancy increases than 
Japan. The UN life expectancy forecasts are below the 0.025 fractile of our life 
expectancy distributions throughout the first half of the century. By 2100, the UN 
forecast is just barely above the 0.025 fractile. Again, from our perspective, the UN 
forecasts seem rather low. 
Population sizes are shown in Figures 7, 8, and 9, and median ages in Figures 10, 
11, and 12. Since mortality paths are the only population change component that varies 
between the UN projections and the new ones given here, the life expectancy changes 
are closely reflected in the population sizes and median ages. The UN projections and 
ours are closest for Japan and most different for the United States, with Germany 
always being an intermediate case. It is easy to misjudge the differences based on these 
graphs. Using the UN forecast, the U.S. population grows on average by 0.4 percent per 
year over the century. Putting Oeppen and Vaupel (2002) to work yields a growth rate 
of 0.5 percent. The U.S. population is only around 12 percent higher in 2100 using the 
new projections than using the UN’s. There would be much more variability in 
measures like the proportion of the population at age 80 and above, but those numbers 
have not yet been published by the UN for 2100, so we cannot make the comparison at 
this time. 
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Figure 6.  Probabilistic forecast of life expectancy and the UN medium variant, USA, females. 
 
Figure 7.  Probabilistic forecast of population size and the UN medium variant, Japan. 
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Figure 8.  Probabilistic forecast of population size and the UN medium variant, Germany. 
 
Figure 9.  Probabilistic forecast of population size and the UN medium variant, USA. 
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Figure 10.  Probabilistic forecast of median age and the UN medium variant, Japan. 
 
Figure 11.  Probabilistic forecast of median age and the UN medium variant, Germany. 
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Figure 12.  Probabilistic forecast of median age and the UN medium variant, USA. 
4. Conclusions 
In this paper we have put Oeppen and Vaupel (2002) to work. The result is a new 
methodology for forecasting life expectancy changes in low mortality countries. Our 
methodology has applied three key lessons that we have learned from Oeppen and 
Vaupel (2002). First, our methodology produces life expectancy forecasts in which the 
immediate future exhibits a continuation of the trends that we have seen in the recent 
past. It was surprising to us to see how few mortality forecasts do this. Second, our 
methodology produces sets of life expectancies in which one country does not remain 
the life expectancy leader into the indefinite future. History shows that the country with 
the best-practice life expectancy changes. Our procedure is consistent with this history, 
while forecasts that assume that the leader today will always be the leader are not. 
Third, our forecasts do not show that life expectancy increases must slow down. We 
allow for the possibility that life expectancy increases could slow down as well as for 
the possibility that they may speed up. 
We have also followed in the spirit of Oeppen and Vaupel (2002). They showed 
that the assessment of many experts on the limitations of human life expectancy have 
consistently been proven wrong. This does not mean that expert opinion on mortality is 
worthless. Indeed, we remain strong believers in the value of expert opinion in 
demographic forecasting generally, but only when that opinion is consistent with 
observations. Expert opinions that invariably fail that test need to be rejected and 
alternatives need to be found. Oeppen and Vaupel (2002) show the power of insightful 
analysis of empirical life expectancy data. In our view, they have produced the best 
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approach to understanding the evolution of life expectancies and we have followed them 
by basing our model and our parameter estimates on the same sorts of data. 
Our work on putting Oeppen and Vaupel (2002) to work is not complete. The 
methodology that we offer here is appropriate only for low mortality countries. An 
analysis that can be used for countries that are catching up to the leaders remains on our 
research agenda. Finally, ours is, of course, only one of the many possible ways of 
putting Oeppen and Vaupel (2002) to work. Others are undoubtedly developing ways to 
do this as well. Certainly, Oeppen and Vaupel (2002) will never be unemployed. 
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